Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01895179 · ClinicalTrials.gov registry record · NA

Comparison of Time-Restricted Feeding Versus Grazing

A NA study of Insulin Resistance and PreDiabetes, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT01895179 is a NA study of Insulin Resistance and PreDiabetes that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 8 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01895179, a NA study of Insulin Resistance and PreDiabetes, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to find out what eating meals in a short time period early in the day (time-restricted feeding) versus eating meals spread out during the day (grazing) does to the body's ability to control blood sugar and to the health of its blood vessels. The investigators hypothesize that time-restricted feeding will be more effective at improving glucose tolerance and vascular condition (inflammation and micro- and macro-vascular function) than grazing.

Interventions

  • OTHER Time-Restricted Feeding
  • OTHER Grazing

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2013-07
Est. Completion 2017-11
Phase NA

What the Registry Record Tells You About NCT01895179

The ClinicalTrials.gov registry entry for NCT01895179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (97% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which Time-Restricted Feeding is the first listed.

NCT01895179 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT01895179 about?

NCT01895179 is a clinical study titled "Comparison of Time-Restricted Feeding Versus Grazing". The purpose of this pilot study is to find out what eating meals in a short time period early in the day (time-restricted feeding) versus eating meals spread out during the day (grazing) does to the body's ability to control blood sugar and to the health of its blood vessels. The investigators hypo...

What is the current status of trial NCT01895179?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-07. Estimated completion is 2017-11.

What conditions does trial NCT01895179 study?

This clinical trial studies the following conditions: Insulin Resistance, PreDiabetes, Vascular Diseases.

What interventions are being tested in trial NCT01895179?

The interventions under investigation include: Time-Restricted Feeding (OTHER), Grazing (OTHER).

Who is sponsoring clinical trial NCT01895179?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01895179 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.